Replacement of sux by remifentanil in intubation (GA) in cesarea

Phase 2

Conditions: muscle relaxant in cesarean intubation.
Failed or difficult intubation

Registration Number: IRCT2013010612035N1

Lead Sponsor: Vice chancellor for research, Zahedan University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: Female

Target Recruitment: 100

Inclusion Criteria

Major inclusion criteria: Iranian pregnant female; ASA class1 and 2; 18-35 years old; BMI 18.5-24.9; without common cold; elective cesarean.
Major exclusion criteria: difficult airway; significant respiratory disease; severe asthma; GERD; neurologic and neuromuscular disease; cardiovascular disease; HTN; DM; allergy to drugs used in this study; organ failure; pregnancy intoxication; GDM; Placental abruption; oligo and polyhydramnious; placental abnormalities; coagulation and fetal abnormalities; opium and alcohol abuse.

Exclusion Criteria

Not provided

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Intubation conditions. Timepoint: soon after intervention. Method of measurement: upon 5 Primary outcome is devided to 3 groups as well, intermediate and bad.;APGAR. Timepoint: at min. 1 and 5 after delivery. Method of measurement: upon APGAR standard scale.

Secondary Outcome Measures

Name	Time	Method
Jaw relaxation. Timepoint: soon after intervention. Method of measurement: upon numeric scale of jaw relaxation.;Laryngoscopy. Timepoint: 1 min. after intervention. Method of measurement: upon numeric scale of laryngoscopy.;Vocal cords. Timepoint: 1 min. after intervention. Method of measurement: upon numeric scale of vocal cords movement.;Bucking after intubation. Timepoint: 1 min after intervention. Method of measurement: upon numeric scale of bucking after intubation.;Limbs movement. Timepoint: soon after intervention. Method of measurement: upon numeric scale of limbs movement after intubation.